LADA (Latent Autoimmune Diabetes) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About LADA (Latent Autoimmune Diabetes)
What is LADA?
Latent Autoimmune Diabetes in Adults, often referred to as "Type 1.5 Diabetes," is a unique form of diabetes that combines features of both Type 1 and Type 2 diabetes. Unlike Type 1, which typically appears in childhood or adolescence with a rapid onset, LADA develops slowly in adults, usually after the age of 30. And unlike Type 2, which is characterized by insulin resistance, LADA is an autoimmune condition where the body's immune system gradually attacks and destroys the insulin-producing beta cells in the pancreas, similar to Type 1 diabetes. However, this destruction happens at a much slower pace.
Because of its gradual onset and adult diagnosis, LADA is frequently misdiagnosed as Type 2 diabetes initially. Patients might respond to oral diabetes medications for a period, but eventually, their insulin production declines significantly, necessitating insulin therapy. A key indicator for LADA is the presence of autoantibodies, such as GAD (glutamic acid decarboxylase) antibodies, which are typically absent in Type 2 diabetes.
Common Treatments and Medications for LADA
Managing LADA focuses on preserving the remaining beta cell function and replacing insulin as needed. Early on, lifestyle adjustments like diet and exercise are important. Oral medications, such as sulfonylureas or GLP-1 receptor agonists, might be used temporarily to stimulate insulin production or improve glucose control. However, as
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.